amoxapine
Megjelenés
| Clinical data | |
|---|---|
| Pronunciation | A-mox-a-peen |
| Trade names | Asendin, others |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a682202 |
| License data | |
| Routes of administration | Oral |
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Bioavailability | >60% |
| Protein binding | 90% |
| Metabolism | Hepatic (cytochrome P450 system) |
| Elimination half-life | 8–10 hours (30 hours for chief active metabolite) |
| Excretion | Renal (60%), feces (18%) |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C17H16ClN3O |
| Molar mass | 313.785 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Főnév
amoxapine (tsz. amoxapines)